Overall survival and disease-free interval according to clinical stage and lymph node status.
- Yue Zhang (30585)
- Shaoqiang Cheng (464399)
- Mingyan Zhang (354597)
- Lina Zhen (464400)
- Da Pang (110728)
- Qingyuan Zhang (435205)
- Zhigao Li (464401)
Publication date
September 2013
DOIAbstract
<p>(A) DFS in stage I-II patients, P = 0.027 (B) OS in stage I-II patients, P = 0.025 (C) DFS in stage III patients, P = 0.134 (D) OS in stage III patients, P<0.001 (E) DFS in node-negative patients, P = 0.033 (F) OS in node-negative patients, P = 0.013. Green: TAM-low group; Blue: TAM-high group.</p
Add to ORKG